| Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
NOT-CA-22-001 |
|
|
11/06/2024 |
|
| Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
NOT-NS-23-002 |
|
|
06/21/2024 |
|
| HEAL Initiative: Understanding Individual Differences in Human Pain Conditions |
RFA-NS-24-021 (R01 - Clinical Trial Optional) |
R01 |
Clinical Trial Optional |
02/07/2025 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative: Studies to Enable Analgesic Discovery |
RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed) |
R61, R33 |
Clinical Trial Not Allowed |
01/16/2027 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery |
NOT-NS-22-095 |
|
|
06/25/2025 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment |
RFA-NS-22-034 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
12/07/2024 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices |
RFA-NS-23-028 (RM1 Clinical Trial Optional) |
RM1 |
Clinical Trial Optional |
06/10/2025 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices |
RFA-NS-23-003 (RM1 Clinical Trial Optional) |
RM1 |
Clinical Trial Optional |
06/10/2025 |
|
| NCI Clinical and Translational Exploratory/Developmental Studies |
PAR-22-216 (R21 Clinical Trial Optional) |
R21 |
Clinical Trial Optional |
07/02/2025 |
Marjorie Perloff, M.D. |
| Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity |
PAR-22-092 (R01 - Clinical Trials Optional) |
R01 |
|
09/08/2024 |
Ellen Richmond, M.S., G.N.P.-B.C. |